Workflow
LSD
icon
Search documents
MOST DISTURBING CIA MIND CONTROL PROJECT...
The Diary Of A CEO· 2026-02-22 18:24
It was damning. They were experimenting on American citizens. I hate conspiracy theories that run a muck.But you know, a former CI director is the one who came up with the term conspiracy theory to discredit people by making them sound like crazy people when in fact there was such a thing called MK Ultra, Operation Grasshopper or MK Chickwit. You the CIA did crazy crazy stuff from roughly 1952 to 1975. The Chinese told us in like that the Russians were using LSD to try to engineer it to be used as a mind co ...
国瓷材料_业绩说明会要点_为下一阶段增长做好准备;维持买入评级
2025-10-30 02:01
Summary of Sinocera Functional Material (300285.SZ) Conference Call Company Overview - **Company**: Sinocera Functional Material - **Ticker**: 300285.SZ - **Market Cap**: Rmb22.7 billion / $3.2 billion - **Industry**: Advanced Materials, specifically fine ceramic materials Key Points from the Conference Call 1. Sales Performance - **3Q25 Sales Growth**: Sales growth was observed across most products, except for MLCC (Multi-layer Ceramic Capacitors) and ceramic bearing balls, which faced challenges due to price discounts and downstream destocking respectively [1][5][10] - **MLCC Sales**: Management noted that MLCC sales were impacted by price discounts on mature products, with a full-year shipment expectation of around 7,000 tons, flat year-over-year [5][10] - **Catalytic Materials**: Experienced solid sales growth of over 30% year-over-year, driven by increased penetration into new models and large customers [5][10] - **Biomedical Materials**: Sales turned positive year-over-year, attributed to a better product mix with high-end products launched [6][10] 2. New Product Developments - **Zirconium Dispersion**: Expected to contribute tens of millions in sales this year, with significant downstream demand noted [8][10] - **AI-server/Auto-grade MLCC**: Anticipated to drive incremental sales next year, with new capacity ramping up [1][10] - **Solid State Battery Electrolyte**: Sampling process has begun, with production lines expected to be completed by year-end, highlighting a high ASP of around Rmb5 million per ton [8][10] 3. Capacity Expansion - **New Capacity**: Management is accelerating the build-out of 5,000 tons of new capacity, with part expected to be completed by year-end [5][10] - **Ceratron Phase II Capacity**: Expected to start testing in 4Q25, positioning the company for growth in the precision ceramics segment [5][10] 4. Financial Guidance - **4Q25 NP Guidance**: Management expects notable year-over-year growth in net profit, driven by a low base from the previous year [5][10] - **2025 NP Growth**: Management is confident in achieving over 10% year-over-year growth for 2025 net profit [5][10] 5. Risks and Challenges - **Market Share Expansion**: Risks include slower-than-expected expansion in ceramic powder market share and customer penetration in the catalytic material business due to technology and quality issues [9][10] - **End-Market Growth**: Slower-than-expected growth in end-markets poses a risk to overall performance [9][10] 6. Valuation and Investment Thesis - **Price Target**: The 12-month target price is set at Rmb25.00, representing an upside of 10.6% from the current price of Rmb22.61 [11][10] - **Investment Thesis**: Sinocera is positioned for long-term growth due to its unique exposure to structural growth opportunities in various end-markets, supported by ongoing R&D and M&A activities [10][11] 7. Financial Metrics - **Revenue Forecasts**: Expected revenue growth from Rmb4,046.6 million in 2024 to Rmb6,513.3 million by 2027 [11][10] - **EBITDA and EPS**: Projected EBITDA growth from Rmb986.7 million in 2024 to Rmb1,681.9 million by 2027, with EPS expected to increase from Rmb0.61 to Rmb0.99 over the same period [11][10] Conclusion Sinocera Functional Material is navigating a challenging market environment with strategic product launches and capacity expansions. The company is well-positioned for future growth, although it faces risks related to market share expansion and end-market growth dynamics. The investment thesis remains positive, supported by a solid valuation and growth prospects.